These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nasal polyp eosinophilia and FeNO may predict asthma symptoms development after endoscopic sinus surgery in CRS patients without asthma. Kurokawa R, Kanemitsu Y, Fukumitsu K, Takeda N, Yap JM, Ozawa Y, Masaki A, Ono J, Izuhara K, Nishiyama H, Fukuda S, Uemura T, Tajiri T, Ohkubo H, Maeno K, Ito Y, Oguri T, Takemura M, Suzuki M, Niimi A. J Asthma; 2022 Jun; 59(6):1139-1147. PubMed ID: 33653221 [Abstract] [Full Text] [Related]
7. Impact of sinus surgery on type 2 airway and systemic inflammation in asthma. Hamada K, Oishi K, Chikumoto A, Murakawa K, Ohteru Y, Matsuda K, Uehara S, Suetake R, Ohata S, Murata Y, Yamaji Y, Asami-Noyama M, Ito K, Edakuni N, Hirano T, Matsunaga K. J Asthma; 2021 Jun; 58(6):750-758. PubMed ID: 32050820 [Abstract] [Full Text] [Related]
11. Combined measurements of fractional exhaled nitric oxide and nasal nitric oxide levels for assessing upper airway diseases in asthmatic patients. Asano T, Takemura M, Kanemitsu Y, Yokota M, Fukumitsu K, Takeda N, Ichikawa H, Hijikata H, Uemura T, Takakuwa O, Ohkubo H, Maeno K, Ito Y, Oguri T, Nakamura A, Maki Y, Nakamura Y, Suzuki M, Niimi A. J Asthma; 2018 Mar; 55(3):300-309. PubMed ID: 28513250 [Abstract] [Full Text] [Related]
12. Diagnostic value of serum and tissue eosinophil in diagnosis of asthma among patients with chronic rhinosinusitis. Che Mat CMH, Md Shukri N, Mohamad S, Tuan Sharif SE, Ramli R, Jais MH, Mat Jaeb MZ, Yaacob NM, Yusoff MY, Husna SMN, Abdullah B. Eur Arch Otorhinolaryngol; 2023 May; 280(5):2283-2291. PubMed ID: 36401099 [Abstract] [Full Text] [Related]
13. Nasal nitric oxide as a marker of sinus mucosal health in patients with nasal polyposis. Lee JM, McKnight CL, Aves T, Yip J, Grewal AS, Gupta S. Int Forum Allergy Rhinol; 2015 Oct; 5(10):894-9. PubMed ID: 26184956 [Abstract] [Full Text] [Related]
14. Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis. Yamada T, Miyabe Y, Ueki S, Fujieda S, Tokunaga T, Sakashita M, Kato Y, Ninomiya T, Kawasaki Y, Suzuki S, Saito H. Front Immunol; 2019 Oct; 10():74. PubMed ID: 30778348 [Abstract] [Full Text] [Related]
15. Eosinophil extracellular trap formation is closely associated with disease severity in chronic rhinosinusitis regardless of nasal polyp status. Hwang CS, Park SC, Cho HJ, Park DJ, Yoon JH, Kim CH. Sci Rep; 2019 May 30; 9(1):8061. PubMed ID: 31147604 [Abstract] [Full Text] [Related]
16. Periostin as a Biomarker for Nasal Polyps in Chronic Rhinosinusitis. Maxfield AZ, Landegger LD, Brook CD, Lehmann AE, Campbell AP, Bergmark RW, Stankovic KM, Metson R. Otolaryngol Head Neck Surg; 2018 Jan 30; 158(1):181-186. PubMed ID: 29040053 [Abstract] [Full Text] [Related]
17. Analysis of comorbidities and objective parameters in refractory chronic rhinosinusitis. Batra PS, Tong L, Citardi MJ. Laryngoscope; 2013 Dec 30; 123 Suppl 7():S1-11. PubMed ID: 24122826 [Abstract] [Full Text] [Related]
19. The diagnostic importance of periostin as a biomarker in chronic rhinosinusitis with nasal polyp. Yilmaz GO, Cetinkaya EA, Eyigor H, Ellidag HY, Balaban K, Selcuk OT, Yilmaz G, Gur OE. Eur Arch Otorhinolaryngol; 2022 Dec 30; 279(12):5707-5714. PubMed ID: 35723731 [Abstract] [Full Text] [Related]
20. Availability of preoperative systemic steroids on endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. Hong SJ, Lee JK, Lee HS, Lee JY, Pyo JS, Lee KC. Yonsei Med J; 2014 Nov 30; 55(6):1683-90. PubMed ID: 25323909 [Abstract] [Full Text] [Related] Page: [Next] [New Search]